SISXF yields 2.11% · JNJ yields 2.13%● Live data
📍 JNJ pulled ahead of the other in Year 10
Combined, SISXF + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of SISXF + JNJ for your $10,000?
Savaria Corporation provides accessibility solutions for the elderly and physically challenged people in Canada, the United States, Europe, and internationally. The company operates in three segments: Accessibility, Patient Care, and Adapted Vehicles. The Accessibility segment designs, manufactures, distributes, and installs accessibility products, such as stairlifts for straight and curved stairs, vertical and inclined wheelchair platform lifts for commercial and residential applications, and accessibility and home elevators. The Patient Care segment manufactures and distributes therapeutic support surfaces and other pressure management products for the medical and medical beds, as well as offers medical equipment and solutions for the safe handling of patients. The Adapted Vehicles segment offers distributing vehicles for people with mobility challenges for personal or commercial use. The company sells its products through dealers and by direct stores to end-user customers. Savaria Corporation was founded in 1979 and is headquartered in Laval, Canada.
Full SISXF Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.